Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 1, 1998, Pages 41-44

  Shalekoff, Sharon ^a,b   Tiemessen, Caroline T ^a   Gray, Clive M ^a,c   Martin, Desmond J ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0031907651     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.1.41-44.1998     Document Type: Article

References (28)

1. Antonaci, S., E. Jirillo, A. Polignano, M. T. Ventura, R. Sabato, and L. Bonoma. 1991. Evaluation of phagocyte functions, inflammatory lymphokinc activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis. Cytobios 67:135-144.
2. Bandres, J. C., J. Trial, D. M. Musher, and R. D. Rossen. 1993. Increased phagocytosis and generation of reactive oxygen products by neutrophils and monocytes of men with stage 1 human immunodeficiency virus infection. J. Infect. Dis. 168:75-83.
3. Brindle, R. J., P. P. Nunn, B. I. F. Batchelor, S. N. Gathua, J. N. Kimari, R. S. Newnham, and P. G. Waiyaki. 1993. Infection and morbidity in patients with tuberculosis in Nairobi, Kenya. AIDS 7:1469-1474.
4. Chen, T. P., R. L. Roberts, K. G. Wu, B. J. Ank, and E. R. Stiehm. 1993. Decreased Superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human-immunodeficiency virus-infected children and adults. Paediatr. Res. 34:544-550.
5. Ellis, M., S. Gupta, S. Galant, S. Hakim, C. VandeVen, C. Toy, and M. S. Cairo. 1988. Impaired neutrophil function in patients with AIDS or AlDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268-1276.
6. Geertsma, M. F., P. H. Nibbering, O. Pos, and R. Van Furth. 1990. Interferon-γ-activated human granulocytes kill ingested Mycobacterium fortuitum more efficiently than norman granulocytes. Eur. J. Immunol. 20:869-873.
7. Isaksson, B., J. Albert, F. Chiodi, A. Furucrona, A. Krook, and P. Putkonen. 1988. AIDS two months after primary human immunodeficiency virus infection. J. Infect. Dis. 158:866-867.
8. Jones, G. S., H. J. Amirault, and B. R. Andersen. 1990. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J. Infect. Dis. 162:700-704.
9. Magnenat, J. L., L. P. Nicod, R. Auckenthaler, and A. F. Junod. 1991. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am. Rev. Respir. Dis. 144:917-922.
10. Mandell, G. L., and L. F. Fuller. 1972. Nitrobluc tetrazolium dye test: a diagnostic aid in tuberculosis. Am. Rev. Respir. Dis. 106:123-125.
11. + lymphocyte count in African patients co-infected with HIV and tuberculosis. J. Acquired Immune Detic. Syndr. Hum. Retrovirol. 8:386-390.
12. Murphy, P. M., H. C. Lane, A. S. Fauci, and J. I. Gallin. 1988. Impairment of neutrophil bactericidal capacity in patients with AIDS. J. Infect. Dis. 158:627-630.
13. Nibbering, P. H., O. Pos, A. Stevenhagen, and R. Van Furth. 1993. Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes. Infect. Immun. 61:3111-3116.
14. Nunn, P., R. Brindle. L. Carpenter, J. Odhiambo, K. Wasunna, R. Newnham, W. Githui, S. Gathua, M. Omwega, and K. McAdam. 1992. Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya: analysis of early (6-month) mortality. Am. Rev. Respir. Dis. 146:849-854.
15. Pape, J. W., S. S. Jean, J. L. Ho, A. Hafner, and W. D. Johnson, Jr. 1993 Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342:268-272.
16. Pitrak, D. L., P. M. Bak, P. DeMarais, R. M. Novak, and B. R. Anderson. 1993. Depressed neutrophil Superoxide production in human immunodeficiency virus infection. J. Infect. Dis. 167:1406-1410.
17. Pos, O., A. Stevenhagen. P. L. Meenhorst, F. P. Kroon, and R. Van Furth. 1992. Impaired phagocytosis of Staphylococcus aureus by granulocytes and monocytes of AIDS patients. Clin. Exp. Immunol. 88:23-28.
18. Raviglione, M. C., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
19. Rieger, M., L. Trnka, J. Skvor, and P. Mison. 1979. Immunoprofile studies in patients with pulmonary tuberculosis. 111. Study of haemolytic complement in serum and phagocylic activity of blood neutrophils. Scand. J. Respir. Dis. 60:172-175.
20. Roilides, E., S. Mertins, J. Eddy, T. J. Walsh, P. A. Pizzo, and M. Rubin. 1990. Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor. J. Pediatr. 117:531-540.
21. Schäfer, V., J. Kreuter, H. Rübsamen-Waigmann, S. Gerte, and H. von Briesen. 1994. Influence of HIV-infection on the phagocytic activity of monoçytes/macrophages and granulocytes. Clin. Diagn. Virol. 1:279-287.
22. Schuchat, A., C. V. Broome, A. Hightower, S. J. Costa, and W. Parkin. 1991. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population. JAMA 265:3275-3279.
23. Taylor, J. M. G., J. L. Fahey, R. Detels, and J. V. Giorgi. 1989. CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J. Acquired Immune Defic. Syndr. 2:114-124.
24. Toossi, Z., J. G. Sierra-Madero, R. A. Blinkhorn, M. A. Mettler, and E. A. Rich. 1993. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J. Exp. Med. 177:1511-1516.
25. Wadee, A. A., J. D. Cohen, and A. R. Rabson. 1987. Gamma interferon reverses inhibition of leukocyte bactericidal activity by a 25-kilodalton fraction from Mycobacterium tuberculosis. Infect. Immun. 55:2777-2782.
26. 2-microglobulin in HIV-1 associated tuberculosis. J. Infect. Dis. 167:43-48.
27. Wenisch, C., B. Parschalk. K. Zedwitz-Liebenstein, W. Graninger, and A. Rieger. 1996. Dysregulation of the polymorphonuclear leukocyte-Candida spp. interaction in HIV-positive patients. AIDS 10:983-987.
28. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.